Filing Flows › Treace Medical Concepts (TMCI) › Q1 2025
Treace Medical Concepts (TMCI) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 8, 2025
Treace Medical Concepts (TMCI) reported revenue of $52.6M for the first quarter 2025 (Q1 2025), +3% from a year earlier and -23% from the quarter before. Operating margin was -29.6%, net loss $15.9M (30.3% of revenue).
Treace Medical Concepts, Q1 2025: revenue $52.6M (+3% year over year), operating margin -29.6%, net loss $15.9M, operating cash flow $4.2M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $52.6M | -23% | +3% |
| Operating profit | −$15.6M | — | — |
| Net earnings | −$15.9M | — | — |
| Operating cash flow | $4.2M | — | — |
| Free cash flow | $655K | — | — |
What changed
Revenue was $52.6M in Q1 2025, up 3% year over year and down 23% from the previous quarter.
Gross margin was 79.7%, down 0.5 points from a year earlier. Operating costs exceeded revenue by $15.6M, an operating margin of -29.6%. Operating expenses fell 4% while revenue rose 3%. The quarter ended with a net loss of $15.9M, wider than the previous quarter's $501K loss.
Operating cash flow was $4.2M. Non-cash charges added back $2.5M of depreciation and amortization and $8.7M of share-based compensation. Working capital and other items added $9.0M. Capital expenditures of $3.5M left free cash flow of $655K.
Questions
What was Treace Medical Concepts' revenue in the first quarter 2025?
Treace Medical Concepts (TMCI) reported revenue of $52.6M for the first quarter 2025 (Q1 2025), +3% from a year earlier and -23% from the quarter before.
Was Treace Medical Concepts profitable in the first quarter 2025?
Operating loss was $15.6M (-29.6% of revenue) and net loss $15.9M.